Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan
Actavis Announces Closing of Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan PR Newswire DUBLIN, March 2, 2015 DUBLIN , March 2, 2015 /PRNewswire/ — Actavis plc (NYSE: ACT) today announced that it has closed its concurrent offerings of 14,513,889 Ordinary Shares at $288.00 per share and 5,060,000 5.500% Mandatory Convertible Preferred Shares, Series A, at $1,000.00 per share, each having been offered in a separate registered public offering. The amounts sold include 1,319,444 Ordinary Shares and 460,000 Mandatory Convertible Preferred Shares issued pursuant to the exercise in full of the over-allotment option granted to the underwriters in each of the respective offerings to purchase additional Ordinary Shares and Mandatory Convertible Preferred Shares, respectively. Logo – http://photos.prnewswire.com/prnh/20130124/NY47381LOGO The net proceeds from the offerings of Ordinary Shares and Mandatory Convertible Preferred Shares were approximately $4.1 billion and $4.9 billion , respectively, in each case after estimated underwriting discounts, commissions and offering expenses payable by Actavis plc […]